This further suggests that IPTF may inhibits NSCLC progression, potentially via regulation of the PI3K/AKT signaling pathway through quercetin, which is consistent with the results predicted in Section 3.1.1 and Section 3.1.2. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.